Covance Inc

Type: Company
Name: Covance Inc
Nationality: United States
Web Address: http://www.covance.com/
Fact Sheet: Fact Sheet for Covance Inc
First reported Sep 17 2014 - Updated Sep 18 2014 - 1 reports

Covance Inc. And Frenova Renal Research Establish Innovative Research Collaboration

Researchers Will Share and Analyze Data to Improve Lives of Patients LivingWith Chronic Kidney Disease and End Stage Renal Disease(Princeton, N.J., and Waltham, Mass., (September 17, 2014) — Covance Inc. (NYSE: CVD), a leading global drug development ... [Published BioSpace - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 17 2014 - 2 reports

Covance Down 13.7% Since SmarTrend Downtrend Call (CVD)

Written on Tue, 09/16/2014 - 6:29pmBy Shiri GuptaSmarTrend identified a Downtrend for Covance ( NYSE:CVD ) on April 7th, 2014 at $98.69. In approximately 5 months, Covance has returned 13.73% as of today's recent price of $85.14.Covance share prices ... [Published Comtex SmarTrend - Sep 17 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Covance (CVD) Showing Support Near $84.71

The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Covance Inc (CVD) that includes 1.78% downside protection. Sell one contract of the Nov. '14 $90.00 ... [Published MarketIntelligenceCenter.com - Sep 12 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Insider Selling: Joseph L. Herring Unloads 32,200 Shares of Covance Stock (CVD)

Covance (NYSE:CVD) CEO Joseph L. Herring sold 32,200 shares of Covance stock on the open market in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $85.13, for a total value of $2,741,186.00. Following ... [Published American Banking News - Forex - Sep 11 2014]
First reported Sep 09 2014 - Updated Sep 10 2014 - 2 reports

Covance (CVD) Trading Near $83.84 Support Level

A covered call identified by MarketIntelligececenter.com's patented algorithm on Covance Inc (CVD) could yield about 3.84% (19.18% annualized, for comparison purposes only) in 73 days. Pair a long position in the stock with the Nov. '14 $85.00 call for ... [Published MarketIntelligenceCenter.com - Sep 10 2014]
First reported Sep 07 2014 - Updated Sep 08 2014 - 3 reports

Covance To Present At The Morgan Stanley Global Healthcare Conference

PRINCETON, N.J.Covance, the world's most comprehensive drug development company and a leader in nutritional analysis, is dedicated to advancing healthcare and delivering Solutions Made Real™Statements contained in this press release, which are not historical ... [Published Stock Nod - Sep 07 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Covance (CVD) Showing Resistance Near $85.41

Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Covance Inc (CVD) that should provide a 3.48% return in just 78 days. Sell one Nov. '14 call at the $85.00 level for each 100 shares of Covance for ... [Published MarketIntelligenceCenter.com - Sep 05 2014]
Entities: Covance Inc, Patent
First reported Sep 02 2014 - Updated Sep 03 2014 - 2 reports

BioLegend Acquires Antibody Products Business Unit From Covance

San Diego-based BioLegend Inc. acquired the shares of Covance Antibody Services Inc., a business unit of Massachusetts-based Covance Inc., on August 29.The Covance Antibody business unit develops and manufactures antibodies and research reagents for neuroscience, ... [Published San Diego Business Journal - Sep 02 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 2 reports

Covance Has Returned 15.9% Since SmarTrend Recommendation (CVD)

Written on Tue, 09/02/2014 - 12:48pmBy James QuinnSmarTrend identified a Downtrend for Covance ( NYSE:CVD ) on April 7th, 2014 at $98.68. In approximately 5 months, Covance has returned 15.93% as of today's recent price of $82.96.In the past 52 weeks, ... [Published Comtex SmarTrend - Sep 02 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Covance Given Consensus Recommendation of “Buy” by Analysts (NYSE:CVD)

Covance (NYSE:CVD) has been given an average recommendation of “Buy” by the fifteen ratings firms that are currently covering the company, StockRatingsNetwork.com reports. Six investment analysts have rated the stock with a hold rating and seven have ... [Published American Banking News - Forex - Aug 29 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

15.0% Return Seen to Date on SmarTrend Covance Call (CVD)

Written on Mon, 08/25/2014 - 11:21amBy James QuinnSmarTrend identified a Downtrend for Covance ( NYSE:CVD ) on April 7th, 2014 at $98.69. In approximately 5 months, Covance has returned 14.95% as of today's recent price of $83.93.Over the past year, ... [Published Comtex SmarTrend - Aug 25 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 2 reports

Covance Retains Balanced View on Steady Growth

we issued an updated research report on Covance Inc. ( CVD - Analyst Report ). Covance has managed to post healthy second-quarter results with earnings beat and in-line revenues on healthy year-over-year growth across both its segments.Adjusted earnings ... [Published Zacks.com - Aug 22 2014]

Quotes

"We are excited to add Covance Antibody's people and products to the BioLegend team" said Gene Lay, president and CEO of BioLegend
Zacks’ analyst wrote, "Covance reported a decent second-quarter 2014, with adjusted EPS of $0.95, which was up 21.8% year over year and ahead of the Zacks Consensus Estimate by $0.02. Revenues were up 8% at $639.5 million, inline with the Zacks Consensus Estimate. Despite increased spending on strategic IT projects, Late-Stage Development continues to grow strongly on the back of better-than-estimated kit volumes in central laboratories and strong performance of Phase II-IV clinical development services. Moreover, after several quarters of drag, Early Development started showing signs of recovery with improvement in clinical pharmacology and toxicology. Although capital spending environment and competitive landscape remain as overhangs, we believe Covance is positioned well to drive growth in the coming quarters. However, the expiry of Sanofi deal in 2015 is a major concern. Currently, we are Neutral on the stock."
According to the Investor Relations section of the firm's website: "Quintiles helps to improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical services, biotechnology and healthcare industries." This is all well and good but it is still not detailed enough so we looked further

More Content

All (172) | News (31) | Reports (0) | Blogs (132) | Audio/Video (0) | Fact Sheets (2) | Press Releases (7)
sort by: Date | Relevance
Covance (CVD) Showing Bullish Technicals With S... [Published MarketIntelligenceCenter.com - Sep 19 2014]
Covance (CVD) Trading Near $83.52 Support Level [Published MarketIntelligenceCenter.com - Sep 18 2014]
Covance Inc. And Frenova Renal Research Establi... [Published BioSpace - Sep 17 2014]
Biggest Movers in Healthcare Stocks Now – AUXL ... [Published InvestorPlace.com - Sep 17 2014]
Covance (CVD) Showing Bearish Technicals With R... [Published MarketIntelligenceCenter.com - Sep 17 2014]
Covance Down 13.7% Since SmarTrend Downtrend Ca... [Published Comtex SmarTrend - Sep 17 2014]
Covance (CVD) Showing Bearish Technicals [Published MarketIntelligenceCenter.com - Sep 16 2014]
Covance (CVD) Showing Bullish Technicals With R... [Published MarketIntelligenceCenter.com - Sep 15 2014]
Covance (CVD) Showing Support Near $84.71 [Published MarketIntelligenceCenter.com - Sep 12 2014]
Covance (CVD) Trading Near $86.96 Resistance Level [Published MarketIntelligenceCenter.com - Sep 11 2014]
Insider Selling: Joseph L. Herring Unloads 32,2... [Published American Banking News - Forex - Sep 11 2014]
Covance (CVD) Trading Near $83.84 Support Level [Published MarketIntelligenceCenter.com - Sep 10 2014]
Covance Has Returned 13.9% Since SmarTrend Reco... [Published Comtex SmarTrend - Sep 09 2014]
Biggest Movers in Healthcare Stocks Now – ANAC ... [Published InvestorPlace.com - Sep 09 2014]
Covance (CVD) Showing Bearish Technicals With S... [Published MarketIntelligenceCenter.com - Sep 09 2014]
Potential Covance (CVD) Trade Has 2.38% Downsid... [Published MarketIntelligenceCenter.com - Sep 08 2014]
Covance To Present At The Morgan Stanley Global... [Published Stock Nod - Sep 07 2014]
Covance : To Present At The Morgan Stanley Glob... [Published 4 Traders - Sep 07 2014]
Covance To Present At The Morgan Stanley Global... [Published PR Newswire: Health - Sep 07 2014]
Covance (CVD) Showing Resistance Near $85.41 [Published MarketIntelligenceCenter.com - Sep 05 2014]
Hottest Healthcare Stocks Now – OMI CBPO CVD MYGN [Published InvestorPlace.com - Sep 05 2014]
Covance (CVD) Showing Support Near $82.91 [Published MarketIntelligenceCenter.com - Sep 04 2014]
Covance (CVD) Sells Antibody Services Unit to B... [Published Zacks.com - Sep 03 2014]
Covance (CVD) Trading Near $83.92 Resistance Level [Published MarketIntelligenceCenter.com - Sep 03 2014]
BioLegend Acquires Antibody Products Business U... [Published San Diego Business Journal - Sep 02 2014]
Covance Has Returned 15.9% Since SmarTrend Reco... [Published Comtex SmarTrend - Sep 02 2014]
BioLegend acquires Antibody Products business u... [Published Reuters - Sep 02 2014]
Covance (CVD) Showing Resistance Near $84.29 [Published MarketIntelligenceCenter.com - Sep 02 2014]
Biggest Movers in Healthcare Stocks Now – AVNR ... [Published InvestorPlace.com - Aug 30 2014]
Potential Covance (CVD) Trade Has 2.81% Downsid... [Published MarketIntelligenceCenter.com - Aug 29 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Covance (CVD) Showing Bullish Technicals With S... [Published MarketIntelligenceCenter.com - Sep 19 2014]
A covered call identified by MarketIntelligececenter.com's patented algorithm on Covance Inc (CVD) could yield about 6.31% (35.97% annualized, for comparison purposes only) in 64 days. Pair a long position in the stock with the Nov. '14 $90.00 call for ...
Covance (CVD) Trading Near $83.52 Support Level [Published MarketIntelligenceCenter.com - Sep 18 2014]
MarketIntelligenceCenter.com's option-trade picking algorithms have identified an attractive covered-call trade on Covance Inc (CVD). Look at the Nov. '14 $85.00 covered call for a net debit in the $82.29 area. This trade has a duration of 65 days. The ...
Covance (CVD) Showing Bearish Technicals With R... [Published MarketIntelligenceCenter.com - Sep 17 2014]
After Tuesday’s trading in Covance Inc (CVD) the option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center uncovered a trade that offers a 6.96% return, or 38.52% annualized (for comparison purposes only), ...
Covance (CVD) Showing Bearish Technicals [Published MarketIntelligenceCenter.com - Sep 16 2014]
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Covance Inc (CVD) that includes 1.58% downside protection. Sell one contract of the Nov. '14 $90.00 ...
Covance (CVD) Showing Bullish Technicals With R... [Published MarketIntelligenceCenter.com - Sep 15 2014]
Covance Inc (CVD) presents a trading opportunity that offers a 6.07% return in just 68 days.A covered call on Covance at the $90.00 level expiring on Nov. '14 offers an assigned return rate of 6.07% or 32.58% annualized. This trade offers 1.57% downside ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
The National Association of Free and Charitable... [Published GlobeNewswire: Advertising News - Aug 28 2014]
Financial Results, Investor Meeting Schedule, D... [Published Financial Services - Jul 30 2014]
New Laws, Pricing of Offering, Recognitions, Do... [Published Financial Services - Jun 30 2014]
Strategic Collaborations and Expanded Repurchas... [Published Financial Services - Jun 10 2014]
Covance To Present At The William Blair 34th An... [Published Financial Services - Jun 09 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.